Design, synthesis, and biological evaluation of novel N-Benzyl piperidine derivatives as potent HDAC/AChE inhibitors for Alzheimer’s disease
Authors:
- 21 January 2023
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 80, 117178
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81903503)
- Natural Science Foundation of Shandong Province (ZR2019MB017)
This publication has 52 references indexed in Scilit:
- The Revitalized Tau Hypothesis on Alzheimer's DiseaseArchives of Medical Research, 2010
- Oxidative stress hypothesis in Alzheimer’s disease: a reappraisalTrends in Pharmacological Sciences, 2008
- Multi-target-Directed Ligands To Combat Neurodegenerative DiseasesJournal of Medicinal Chemistry, 2008
- Metals and amyloid‐β in Alzheimer's diseaseInternational Journal of Experimental Pathology, 2005
- How important is oxidative damage? Lessons from Alzheimer’s diseaseFree Radical Biology and Medicine, 2000
- The cholinergic hypothesis of Alzheimer's disease: a review of progressJournal of Neurology, Neurosurgery & Psychiatry, 1999
- Allosteric Modulation of Acetylcholinesterase Activity by Peripheral Ligands Involves a Conformational Transition of the Anionic SubsiteBiochemistry, 1995
- Oxidative Stress, Glutamate, and Neurodegenerative DisordersScience, 1993
- Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body typesJournal of Neural Transmission, 1990
- A new and rapid colorimetric determination of acetylcholinesterase activityBiochemical Pharmacology, 1961